ELF3 and benign prostatic hyperplasia: Therefore, the study presented here used alternative cell line models (BPH‐1 and PC3 cells), based on their expression levels of ELF3, and patient‐derived primary prostate epithelial cells and patient tissue microarrays to further elucidate the role of ELF3 in both normal prostate growth and PCa.